Evidence map›Paper›PMID 12122111›Full record

ArticleThe Journal of clinical investigation2002

Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy.

Michelle L Chaisson, John T Brooling, Warren Ladiges, Sophia Tsai, Nelson Fausto

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Review
  3. 6-Antioxidants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michelle L ChaissonDepartment of Pathology, University of Washington, Seattle 98195, USA.
John T Brooling
Warren Ladiges
Sophia Tsai
Nelson Fausto
University of Washington · USBaylor College of Medicine · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
GENE EXPRESSION IN REGENERATING AND NEOPLASTIC LIVERSR37CA023226 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 2001 to 2009
$3.1M
Pathogenesis of Hepatocellular CarcinomasR01CA074131 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 1997 to 2010
$3.1M
MOLECULAR TRAINING PROGRAM IN CANCER RESEARCH - COMPETINT32CA009437 · NCI · UNIVERSITY OF WASHINGTON · PI LOEB, LAWRENCE A · 1985 to 2001
$1.1M
GENE EXPRESSION IN REGENERATING AND NEOPLASTIC LIVERSR01CA023226 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 1985 to 2000
$359k
NCI NIH HHS CA-09437NCI NIH HHS CA-23226NCI NIH HHS CA-74131NCI NIH HHS R01 CA023226NCI NIH HHS R01 CA074131NCI NIH HHS R37 CA023226NCI NIH HHS T32 CA009437NIGMS NIH HHS GM-07270NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

One of the earliest TNF-dependent events to occur during liver regeneration is the activation of the transcription factor NF-kappaB through TNF receptor type 1. NF-kappaB activation in the liver can have both antiapoptotic and proliferative effects, but it is unclear which liver cell types, hepatocytes or nonparenchymal cells (NPCs), contribute to these effects. To specifically evaluate the role of hepatocyte NF-kappaB, we created GLVP/DeltaN-IkappaB(alpha) transgenic mice, in which expression of a deletion mutant of IkappaB(alpha) (DeltaN-IkappaB(alpha)) was induced in hepatocytes after injection of mifepristone. In control mice, injection of 25 microg/kg TNF caused NF-kappaB nuclear translocation in virtually all hepatocytes by 30 minutes and no detectable apoptosis, while in mice expressing DeltaN-IkappaB(alpha), NF-kappaB nuclear translocation was blocked in 45% of hepatocytes, leading to apoptosis 4 hours after TNF injection. In contrast, expression of DeltaN-IkappaBalpha in hepatocytes during the first several hours after partial hepatectomy did not lead to apoptosis or decreased proliferation. As NF-kappaB activation was not inhibited in liver NPCs, it is likely that these cells are responsible for mediating the proliferative and antiapoptotic effects of NF-kappaB during liver regeneration.

Indexed as

I-kappa B ProteinsActive Transport, Cell NucleusAnimalsApoptosisCell DivisionDNA-Binding ProteinsGene ExpressionHepatectomyHepatocytesInterleukin-6Liver RegenerationMiceMice, Inbred C57BLMice, TransgenicMifepristoneNF-kappa BDNA-Binding ProteinsI-kappa B ProteinsInterleukin-6MifepristoneNF-kappa BNF-KappaB Inhibitor alphaNfkbia protein, mouseStat3 protein, mouseSTAT3 Transcription FactorTrans-ActivatorsTumor Necrosis Factor-alpha

Identifiers

PMID12122111
PMCPMC151057
OpenAlexW2063687854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.